Rime Bioinformatics logo — Making high performance bioinformatics accessible.

Rime Bioinformatics

Making high performance bioinformatics accessible.

Founded 2021 France France 5 employees Non Equity Assistance Biotechnology, Clean Energy

General Information

Company Name Rime Bioinformatics
Founded Year 2021
Location France France +1
Employees 5
Industries Biotechnology, Clean Energy
Funding Stage Non Equity Assistance
Social

Get notified when Rime Bioinformatics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rime Bioinformatics

Rime Bioinformatics, founded in 2021, is a research and development biotechnology company headquartered in France. Specializing in bioinformatics, their slogan, "Making high performance bioinformatics accessible," underscores their mission to democratize cutting-edge bioinformatics.

The company focuses on expediting research in medical, agronomic, and veterinary fields. Their services provide comprehensive insights into bacterial and bacteriophage genomes, a critical step for advancing phage therapy in the market. This focus aligns well with the industry's increasing emphasis on sustainable and safe therapeutic solutions.

Positioned at the intersection of Biotechnology and Clean Energy, Rime Bioinformatics benefits from the supportive backing of AGORANOV, which provided non-equity assistance in June 2022. As it seeks to expand its influence in bioinformatics and phage therapy, Rime Bioinformatics is poised for growth in dynamic and environmentally conscious sectors.

Taxonomy: Bioinformatics, Phage Therapy, Bacteriophage Genomics, Metagenomics, R&D in Biotechnology, Medical Research Acceleration, Agronomic Research, Veterinary Research, Bacterial Genomes, Genome Analysis, Bioinformatics Accessibility, Environmental Safety in Phage Therapy, Biotech Innovation

Services & Products

High-performance Bioinformatics Analysis
Phage Therapy Analysis
DNA/RNA Sequencing Data Analysis
Development of Analysis Methods for Phage Genomes

Target Customers

Biologists Medical Researchers Agronomy Experts Veterinary Researchers Pharmaceutical Companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Unknown 1 01 Jun 2022

Rime Bioinformatics Alternatives & Competitors

Rime Bioinformatics vs

Pioneering phage-based veterinary solutions for a healthier future in animal husbandry.

Series A
Biotechnology, Health Care
Rime Bioinformatics vs

To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cures for ba...

Acquired
28 employees
Biotechnology, Health Care
Rime Bioinformatics vs

Software & Service for Proteomic LC-MS/MS Analysis and Antibody Characterization

44 employees
Analytics, Biotechnology

FAQ About Rime Bioinformatics

Making high performance bioinformatics accessible.
Rime Bioinformatics was founded in 2021.
Rime Bioinformatics is headquartered in France.
Rime Bioinformatics operates in the following industries: Biotechnology, Clean Energy.
Rime Bioinformatics has approximately 5 employees.
Rime Bioinformatics has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Rime Bioinformatics offers: High-performance Bioinformatics Analysis, Phage Therapy Analysis, DNA/RNA Sequencing Data Analysis, Development of Analysis Methods for Phage Genomes.
Top alternatives and competitors to Rime Bioinformatics include No-Antibiotics, Adaptive Phage Therapeutics, Bioinformatics Solutions Inc., Bioinformatics Institute, Armata Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rime Bioinformatics and No-Antibiotics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rime Bioinformatics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy